Fellows Posters

(8-001) Impact of Coronary Care Unit Clinical Pharmacist in Private Hospital in Saudi Arabia

(8-002) The Influence of hsa-miR-370-3p and CYP2D6 on Steady-state Concentration of Desipramine in Patients with Depressive Disorder

(8-003) Physical Compatibility of Sulbactam-Durlobactam with Select Intravenous Drugs During Simulated Y-site Administration

(8-004) Review of Current and Upcoming Therapies of Huntington’s Disease

(8-006) Evaluating the Impact of Proton Pump Inhibitors on the Effectiveness of Immune Checkpoint Inhibitors in Patients with Advanced Non-Small Cell Lung Cancer: A Retrospective Review

(8-007) Restricting Access of FDA-Approved Medications Risks Patient Safety: A Comprehensive Literature Evaluation

(8-008) Interventions to Address Health Professional Student Stress Relative to High-Stakes Examinations: A Scoping Review

(8-009) Areas Outside the Curve: Limitations in Guidelines Leave Clinicians Asking If Current Practices Are Best for LTACH Patients. a Retrospective Analysis on Vancomycin Kinetic Dosing

(8-010) Impact of Pharmacy-Related Memes on Students' Professional Identity Formation

(8-011) Diabetes Management in Maryland Department of Public Safety and Correctional Services

(8-012) Evaluation of Blood Pressure Assessment Skills for Students in the Pharmacy Curriculum

(8-013) Diversity, Equity, and Inclusion in Clinical Trials: Evaluation of Patient Ethnicity, Sex, and Age in Phase III Trials for Multiple Sclerosis

(8-014) Retrospective Review of Scholarship Activities Among Post-PharmD Biopharmaceutical Industry Fellows

(8-015) Comparing Contemporaneous Approvals of Tumor Agnostic Drugs with or Without Companion Diagnostics in the United States

(8-016) Evaluation of Student Pharmacists' Confidence and Examination Performance with Small Group Recitation in Addition to Standard Lecture in a Required Therapeutics Course

(8-018) Impact of Telehealth Implementation During COVID-19 Pandemic for Opioid Use Disorder Patients: A Scoping Review

(8-019) Trends in Orphan Drug Designation Products Approved by the Food Drug Administration (FDA) Between 2017-2022

(8-020) IPHARM: Using Pharmacists to Connect Montana's Rural Residents to Healthcare Services

(8-021) Digital Innovation in Medical Information: A Technology Benchmarking Survey of phactMI Member Companies

(8-022) Trends in the Inclusion of Patients with Brain Metastases in Phase 2 and Phase 3 Advanced Non-Small Cell Lung Cancer Clinical Trials

(8-023) Advancing Education on Biosimilars Act and Inflation Reduction Act: Will the US Biosimilar Market Match the Approval and Usage Pattern Success of the EU Market?

(8-024) Review of Established and Adapted Criteria for User Experiences Associated with Medical Information Websites and Medical Affairs/Medical Education Websites

(8-025) Effects of the COVID-19 Pandemic on Opioid Abuse in the United States: Results from a Literature Review

(8-026) Assessing Variations in Reporting Race & Ethnicity Related to COVID-19 Mortality During the Pandemic: 2020-2022

(8-027) Non-Alcoholic Steatohepatitis Hepatitis: Unmet Needs and Current Investigational Landscape

(8-028) Impact of the Inflation Reduction Act on Patient Access and out of Pocket Costs

(8-029) A Review of Career Pathways for Fellows Who Complete the Rutgers Pharmaceutical Industry Fellowship Program

(8-030) Evaluation of Antibiotic Use in Multidrug Resistant Gram-Negative Infections

(8-031) Characterization of Post-COVID Conditions in the United States: Literature Review

(8-032) Evaluation of Scientific Response Documentation in a Non-Profit Online Repository Service

(8-033) Assessing Regulatory Strategies of CAR-T Cell Therapies Across Various Health Authorities

(8-034) Revisiting National Trends in USP 797 Pharmaceutical Compounding - Literature Review and Best Practices

(8-035) Triple Negative Breast Cancer: Current Treatments and Pipeline Therapies

(8-036) Evaluation of a Hybrid Human-electronic Data Collection Process for Determining Alignment of Periprocedural Anticoagulation Practices at a Rural Medical Center: A Retrospective Quality Improvement Study

(8-037) Factors Influencing Students' Selection of a School of Pharmacy

(8-038) Utilization of Sodium-Glucose Cotransporter-2 Inhibitors (SGLT2i) in Patients Admitted for Acute Heart Failure Exacerbation

(8-039) Trends in Higher Cost Medication Utilization and Spending for Psoriasis and Gastroenterological Conditions Within an Integrated Delivery Network

(8-040) Bioconjugated Nanometals and Cancer Therapy: A Pharmaceutical Perspective

(8-042) Galenic Development and Effectiveness Evaluation of a Topical Gel of Amikacin 2% and Colistin 1%

(8-043) Drug-resistent Epilepsy in Lennox-Gastaut and Dravet Syndrome: New Challenges in Pharmaceutical Care for Pediatric Patients

(8-044) Impact of Pharmaceutical Medication Reconciliation on Surgical Patient Safety During Transitions of Care

(8-045) Effectiveness of Nirmatrelvir/ritonavir in Hospitalized Adults with COVID-19

(8-046) Oral Health in Pediatric Palliative Care. a Pharmaceutical Point of View Regarding Toxicity and Ketogenic Diet

(8-047) Real-Life Efficacy of Trabectedin in the Treatment of Soft Tissue Sarcomas. Beyond L-Sarcomas

(8-048) Programmed Cell Death Protein 1 Blockade in Tumors with Microsatellite Instability: Beyond Clinical Trials

(8-049) Analysis of Medication Errors Involving High-risk Patients in the Perioperative Setting

(8-050) Virtual Community for the Comprehensive Support of Breast Cancer Patients

(8-051) Design of a New Tool to Analyze the Economic Benefit of Lung Cancer Clinical Trials at the Pharmacy Department

(8-052) Treosulfan-based Conditioning Regimen for Allogeneic Hematopoietic Stem Cell Transplantation in Children with Sickle Cell Disease. Efficacy and Safety

(8-053) Interactions Between Antineoplastic Agents and Complementary and Alternative Medicine in Clinical Practice

(8-055) Study of Defibrotide Use in Pediatrics and Compliance with a New Diagnostic Scale for Sinusoidal Occlusive Syndrome

(8-056) Evaluation of Sleep Quality in Patients with Autoimmune Inflammatory Rheumatologic Disease Treated with Biological Therapies or Small Molecules

(8-057) Results from the Use of Remdesivir During the SARS-COV-2 Pandemy

(8-058) Use of Dalbavancin in Gram-positive Infections. a Real-life Experience in a Tertiary Referral Hospital

(8-059) Current Drug Information Fellows’ Occupational Expectations and Fellowship Graduate Job Placement

(8-060) Detection and Discussion of Designer Stimulants via Mass Spectrometry Testing from Patients Across the United States

(8-061) Optimizing Package Sizes to Reduce Waste of Single-Dose Medications with Weight-Based Dosing

(8-062) Tattoo Ink Accumulation in the Lymphatic System: A Review of Literature

(8-063) Evaluation of Integrated Delivery Network Specialty Pharmacy Services on Total Healthcare Costs

(8-064) Evaluation of Clinical Decision Support to Improve Care for Patients with Atrial Fibrillation at Increased Stroke Risk: 2-Year Results

(8-065) Chronic Metformin Use Is Associated with Reduced Risk of Sepsis in Those Without Type 2 Diabetes

(8-066) Comparison of Clinical Outcomes, Healthcare Utilization and Costs Associated with Newer Diabetes Medication in Patients with Type 2 Diabetes

(8-067) Management of an HIV Co-infected Hepatitis C Patient with Esophagitis and the Inability to Swallow Pills

(8-069) Perception of the Biopharmaceutical Industry in Terms of Stress Due to the Implications of the COVID-19 Pandemic

(8-070) Gefitinib Loaded PLGA Polymeric Nanoparticles and Chitosan Coated PLGA Nanoparticles with Magnified Cytotoxicity Against A549 Lung Cancer Cell Lines